Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 1.5T | 1.2T | 1.1T | 1.1T |
Cost of revenue | 1.4T | 1.1T | 1.0T | 1.0T |
Gross profit | 135.6B | 92.9B | 83.2B | 61.9B |
Operating expense | ||||
Research & development | 1.4B | 2.4B | 394.3M | 456.9M |
Selling general and admin | 4.9B | 5.1B | 4.9B | 4.9B |
Other operating expenses | — | 2.4B | 394.3M | 456.9M |
Operating income | 71.5B | 61.3B | 29.5B | 24.5B |
Non operating interest income | ||||
Income | 1.7B | 1.3B | 522.4M | 1.2B |
Expense | 7.9B | 9.3B | 11.7B | 7.8B |
Other income expense | — | — | — | — |
Pretax income | 44.1B | 23.4B | 11.0B | 9.0B |
Tax provision | 12.9B | 6.4B | 2.0B | 1.9B |
Net income | 31.2B | 17.0B | 8.9B | 7.1B |
Basic EPS | — | — | — | 0.7 |
Diluted EPS | — | — | — | 0.7 |
Basic average shares | — | — | — | 8.7B |
Diluted average shares | — | — | — | 8.7B |
EBITDA | 54.7B | 53.0B | 12.2B | 21.3B |
Net income from continuing op. | — | — | — | — |
Minority interests | 370.0M | -1.4B | 2.9B | -1.0B |
Preferred stock dividends | 0 | 0 | 0 | 0 |